The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.
Ewert, Matt, "Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA" (2013). USF Patents. 257.
University of South Florida